This case highlights the diagnostic and management challenges of refractory multisystem sarcoidosis progressing over a two-year period despite advanced biologic therapy.
🎯 Background & Rationale
Endobronchial valve (EBV) placement is an established bronchoscopic treatment for reducing hyperinflation in severe COPD, relying on strict physiological eligibility criteria: total lung capacity (TLCpleth ≥ 100%) and residual volume (RVpleth ≥ 175%) measured via body plethysmography. However, body plethysmography is frequently unfeasible in this severely ill population due to claustrophobia, large body habitus, inability to perform panting maneuvers, or dependence on supplemental oxygen. This study addresses the clinical gap of how to accurately triage EBV candidates when body plethysmography is unavailable, evaluating alternative modalities including the helium dilution technique, inspiratory/expiratory CT-based volumetry, and spirometry.
👥 Study Design & Population
- Study Type: Single-center observational study.
- Population: 41 COPD patients recruited from the outpatient clinic of St. Marianna University Hospital.
- Patient Demographics & Stratification: Among the cohort, 17.1% (n = 7) met both TLC ≥ 100% and RV ≥ 175% criteria; 53.7% (n = 22) met the TLC criterion alone; and 29.3% (n = 12) met neither.
📈 Methodology & Rigor
- Measurements: Participants underwent spirometry (VC, FVC, FEV₁), body plethysmography (TLCpleth, RVpleth), the helium dilution technique (TLCHe, RVHe), and full-inspiration/expiration chest CT scanning analyzed via VIDA software for air volume (AV) and total lung volume (TLV). Additionally, previously proposed predictive models (Groningen and Pittsburgh models) were applied.
- Statistical Analysis: Linear regression evaluated correlations between alternative measures and plethysmography. ROC curve analyses determined AUCs, and threshold values were established for 100% sensitivity (rule-out threshold) and 100% specificity (rule-in threshold) using stratified bootstrap resampling (2,000 resamples).
🔬 Key Findings
- Diagnostic Performance: Alternative measurements (including TLCHe, inspiratory/expiratory CT volumes, Groningen model metrics, and Pittsburgh model estimates) correlated well with plethysmographic standards and yielded high ROC AUC values ranging from 0.924 to 0.937 for predicting EBV eligibility criteria.
- Systematic Bias: Helium dilution systematically underestimated TLC and RV compared to body plethysmography by mean differences of 0.71 L and 0.81 L, respectively, driven by gas-trapping and airway obstruction.
- Rule-in / Rule-out Thresholds:
- For predicting RVpleth ≥ 175%, the helium dilution method (RVHe using Nishida reference equations) established a rule-in threshold of ≥ 170.5% (100% specificity/PPV) and a rule-out threshold of < 117.4% (100% sensitivity/NPV).
- Spirometric indices showed utility in ruling out ineligibility; an FEV₁ threshold of ≤ 39.2% predicted yielded 100% sensitivity for RVpleth ≥ 175%.
⚖️ Critical Appraisal
- Limitations: The study is limited by its single-center design, small sample size (N = 41), and small subset of patients meeting the RVpleth ≥ 175% threshold (n = 7).
- Methodological Challenges: Discrepancies observed between absolute values largely stem from differences in reference equations (e.g., ECCS93 vs. Nishida vs. GLI-2021) and the physiological differences between gas distribution (helium/CT) and thoracic displacement (plethysmography).
- Generalizability: While the AUCs indicate strong discriminative ability, the narrow subgroup of eligible patients impacts the precision of the derived cutoff thresholds, necessitating multi-center external validation.
💡 The Clinical Bottom Line
Body plethysmography remains the gold standard and mandatory prerequisite for assessing lung volumes prior to EBV placement whenever feasible. However, when patients cannot tolerate or perform plethysmography, alternative metrics—such as helium dilution, CT-based lung volumetry, or validated predictive equations—provide reliable rule-in and rule-out thresholds to safely triage patients, reserving plethysmography strictly for cases falling within the indeterminate intermediate range.
Abstract
Keep reading
N opens the next oneClinicians should note that the presence of targetable mutations in non-small cell lung cancer with malignant pleural disease is not associated with improved survival, based on the findings from this study.
Shape-sensing robotic-assisted bronchoscopy achieved a strict diagnostic yield of 70.2% with a low pneumothorax rate of 3.3%, demonstrating that earlier tissue diagnosis of very small pulmonary nodules is feasible and safe for clinical practice.
CT-guided fiducial placement remains a relevant technique for pre-procedural localization of peripheral lung lesions.
This study introduces ultrasound-guided trans-cannula cryobiopsy of supraclavicular lymph nodes as a novel superficial lymph node approach for tissue acquisition in 10 consecutive patients, though specific numeric success or safety results were not provided in the abstract.
Active infection is not an absolute contraindication to endobronchial valve placement, but positive pressure ventilation significantly increases clinical failure odds with an aOR of 3.00 at P < 0.001.